Article
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
2021-01-19
Abstract excerpt
To date severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 100 million individuals resulting in over two million deaths. Many vaccines are being deployed to prevent coronavirus disease 2019 (COVID-19) including two novel mRNA-based vaccines 1,2 . These vaccines elicit neutralizing antibodies and appear to be safe and effective, but the precise nature of the elicited antibodies is not k...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4c526d7f-f7bf-57df-a0f8-af0f67e5ea56
- DOI
- 10.1101/2021.01.15.426911
